Buscar
Mostrando ítems 1-10 de 434
Miltefosine and cutaneous leishmaniasis
(Lippincott, Williams & Wilkins, 2020)
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial
(Public Library of Science, 2020)
Clinical healing of antimony - resistant cutaneous or mucocutaneous Leishmaniasis following the combined administration of IFN-g and pentavalent antimonials (Sb v)
(Acta Andina, 1993)
In a phase II open trial, combined therapy with SbV (10mg/kg body weight), and recombinant human IFN-g (100 µg/m2 body surface area), was administered to 13 patients with diagnosis of cutaneous or mucocutaneous leishmaniasis, ...